cb-012
caribou,crispr
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'cb-012', 'cll', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'caribou', 'crispr']
just announced at #aacr2023: caribou biosciences presents preclinical data for cb-012, a crispr-edited allogeneic anti-cll-1 car-t cell therapy for treating relapsed or refractory aml. #cancerresearch #crisp 
Passionate about early drug discovery and the potential of cell-based therapies, with a focus on CAR-T. Views my own. #celltherapy #drugdiscovery #CART